New drug combo tested for tough cancers
Disease control
Recruiting now
This study is for people with advanced solid tumors that have not responded to standard treatments. It tests a new drug called CKD-512, given alone or with another drug (pembrolizumab), to find safe doses and see how the body handles it. The goal is to control the disease, not cu…
Phase: PHASE1 • Sponsor: Chong Kun Dang Pharmaceutical • Aim: Disease control
Last updated Apr 29, 2026 04:29 UTC